Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Ruidan Bai
ResearcherPublications, citations & collaboration network
Ruidan Bai is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 5 works, 164 citations, an h-index of 5 and an i10-index of 4.
5
Works
164
Citations
5
h-index
4
i10-index
IDs:OpenAlex
How has Ruidan Bai's publication output changed over time?
ScholarIQpublication output · 2016–2023
Output grew0% over the shown period — from 1 works in 2016 to 1 in 2023.
1
2
1
1
2016201720182023
What are the most-cited papers on Ruidan Bai?
ScholarIQmost cited works
Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis
Cuiyuan Huang, Hong Zhang, Ruidan Bai
Acta Pharmaceutica Sinica B. 201760 CitationsOPEN ACCESS
Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells
Jian Lv, Ruidan Bai, Li Wang, Jiefang Gao, Hong Zhang
BMC Pharmacology and Toxicology. 201845 CitationsOPEN ACCESS
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Tiantian Li, Bo Zhang, Hui Fang, Ming Shi, Weiqi Yao, Yuanyuan Li, Chao Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Xin Yuan, Junliang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Ziying Zhang, Mengqi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei‐Fen Xie, Yonggang Li, Lei Shi, Fu‐Sheng Wang
EBioMedicine. 202334 CitationsOPEN ACCESS
<i>ABCC2</i>(1249G > A) polymorphism implicates altered transport activity for sorafenib
Dan-Yun Wei, Hong Zhang, Rui Peng, Cuiyuan Huang, Ruidan Bai
S48760969. 201619 Citations
A896G and C1196T Polymorphisms Within the <i>TLR4</i> Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells
Cuiyuan Huang, Hong Zhang, Ruidan Bai, Li Wang, Jian Lv
S97146013. 20176 Citations
Related on ScholarIQ
Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis
Paper
Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells
Paper
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Paper
<i>ABCC2</i>(1249G > A) polymorphism implicates altered transport activity for sorafenib
Paper
A896G and C1196T Polymorphisms Within the <i>TLR4</i> Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells
Paper
COVID-19 Clinical Research Studies
Topic